Búsqueda | Biblioteca Virtual en Salud

1.

Validity and Reliability of Clinical Examination in the Diagnosis of Myofascial Pain Syndrome and Myofascial Trigger Points in Upper Quarter Muscles.

Mayoral Del Moral, Orlando; Torres Lacomba, María; Russell, I Jon; Sánchez Méndez, Óscar; Sánchez Sánchez, Beatriz.

Pain Med ; 19(10): 2039-2050, 2018 10 01.

Artículo en Inglés | MEDLINE | ID: mdl-29253210

2.

The fibromyalgia family study: a genome-wide linkage scan study.

Arnold, Lesley M; Fan, Jinbo; Russell, I Jon; Yunus, Muhammad B; Khan, Muhammad Asim; Kushner, Irving; Olson, Jane M; Iyengar, Sudha K.

Arthritis Rheum ; 65(4): 1122-8, 2013 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-23280346

3.

Reply to "Clinical Examination in the Diagnosis of Myofascial Pain Syndrome; Methodological Issues on Validity and Reliability".

Mayoral Del Moral, Orlando; Torres Lacomba, María; Russell, I Jon; Sánchez Méndez, Óscar; Sánchez Sánchez, Beatriz.

Pain Med ; 19(12): 2574, 2018 12 01.

Artículo en Inglés | MEDLINE | ID: mdl-29788501

4.

Elevated serum high-sensitivity C-reactive protein levels in fibromyalgia syndrome patients correlate with body mass index, interleukin-6, interleukin-8, erythrocyte sedimentation rate.

Xiao, Yangming; Haynes, Wanda L; Michalek, Joel E; Russell, I Jon.

Rheumatol Int ; 33(5): 1259-64, 2013 May.

Artículo en Inglés | MEDLINE | ID: mdl-23124693

5.

A brain-derived neurotrophic factor polymorphism Val66Met identifies fibromyalgia syndrome subgroup with higher body mass index and C-reactive protein.

Xiao, Yangming; Russell, I Jon; Liu, Ya-Guang.

Rheumatol Int ; 32(8): 2479-85, 2012 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-21773883

6.

Revised chronic widespread pain criteria: development from and integration with fibromyalgia criteria.

Wolfe, Frederick; Butler, Stephen H; Fitzcharles, MaryAnn; Häuser, Winfried; Katz, Robert L; Mease, Philip J; Rasker, Johannes J; Russell, Anthony S; Russell, I Jon; Walitt, Brian.

Scand J Pain ; 20(1): 77-86, 2019 12 18.

Artículo en Inglés | MEDLINE | ID: mdl-31596726

7.

Fibromyalgia syndrome: approach to management.

Russell, I Jon.

CNS Spectr ; 13(3 Suppl 5): 27-33, 2008 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-18323771

8.

Fibromyalgia syndrome: presentation, diagnosis, differential diagnosis, and vulnerability.

Russell, I Jon; Raphael, Karen G.

CNS Spectr ; 13(3 Suppl 5): 6-11, 2008 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-18323767

9.

Normal cerebrospinal fluid levels of hypocretin-1 (orexin A) in patients with fibromyalgia syndrome.

Taiwo, Oludare B; Russell, I Jon; Mignot, Emmanuel; Lin, Ling; Michalek, Joel E; Haynes, Wanda; Xiao, Yangming; Zeitzer, Jamie M; Larson, Alice A.

Sleep Med ; 8(3): 260-5, 2007 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-17369087

10.

An internet survey of 2,596 people with fibromyalgia.

Bennett, Robert M; Jones, Jessie; Turk, Dennis C; Russell, I Jon; Matallana, Lynne.

BMC Musculoskelet Disord ; 8: 27, 2007 Mar 09.

Artículo en Inglés | MEDLINE | ID: mdl-17349056

11.

CSF versus serum leptin in narcolepsy: is there an effect of hypocretin deficiency?

Arnulf, Isabelle; Lin, Ling; Zhang, Jing; Russell, I Jon; Ripley, Beth; Einen, Mali; Nevsimalova, Sonia; Bassetti, Claudio; Bourgin, Patrice; Nishino, Seiji; Mignot, Emmanuel.

Sleep ; 29(8): 1017-24, 2006 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-16944669

12.

The promise of substance P inhibitors in fibromyalgia.

Russell, I Jon.

Rheum Dis Clin North Am ; 28(2): 329-42, 2002 May.

Artículo en Inglés | MEDLINE | ID: mdl-12122921

13.

Fibromyalgia syndrome: case-based learning.

Russell, I Jon.

CNS Spectr ; 14(10 Suppl 8): 4-7; discussion 17-8, 2009 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-20128142

14.

Fibromyalgia syndrome: new developments in pathophysiology and management. Introduction.

Russell, I Jon.

CNS Spectr ; 13(3 Suppl 5): 4-5, 2008 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-18323766

15.

Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine.

Bennett, Robert; Russell, I Jon; Choy, Ernest; Spaeth, Michael; Mease, Philip; Kajdasz, Daniel; Walker, Daniel; Wang, Fujun; Chappell, Amy.

Clin Ther ; 34(4): 824-37, 2012 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-22421576

16.

Future perspectives in generalised musculoskeletal pain syndromes.

Russell, I Jon.

Best Pract Res Clin Rheumatol ; 25(2): 321-31, 2011 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-22094205

17.

Genetic polymorphisms of the beta2-adrenergic receptor relate to guanosine protein-coupled stimulator receptor dysfunction in fibromyalgia syndrome.

Xiao, Yangming; He, Weijing; Russell, I Jon.

J Rheumatol ; 38(6): 1095-103, 2011 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-21406495

18.

Estimation of minimum clinically important difference for pain in fibromyalgia.

Mease, Philip J; Spaeth, Michael; Clauw, Daniel J; Arnold, Lesley M; Bradley, Laurence A; Russell, I Jon; Kajdasz, Daniel K; Walker, Daniel J; Chappell, Amy S.

Arthritis Care Res (Hoboken) ; 63(6): 821-6, 2011 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-21312349

19.

Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia.

Wolfe, Frederick; Clauw, Daniel J; Fitzcharles, Mary-Ann; Goldenberg, Don L; Häuser, Winfried; Katz, Robert S; Mease, Philip; Russell, Anthony S; Russell, I Jon; Winfield, John B.

J Rheumatol ; 38(6): 1113-22, 2011 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-21285161

20.

Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia.

Mease, Philip J; Russell, I Jon; Kajdasz, Daniel K; Wiltse, Curtis G; Detke, Michael J; Wohlreich, Madelaine M; Walker, Daniel J; Chappell, Amy S.

Semin Arthritis Rheum ; 39(6): 454-64, 2010 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-19152958

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

Validity and Reliability of Clinical Examination in the Diagnosis of Myofascial Pain Syndrome and Myofascial Trigger Points in Upper Quarter Muscles.

The fibromyalgia family study: a genome-wide linkage scan study.

Reply to "Clinical Examination in the Diagnosis of Myofascial Pain Syndrome; Methodological Issues on Validity and Reliability".

Elevated serum high-sensitivity C-reactive protein levels in fibromyalgia syndrome patients correlate with body mass index, interleukin-6, interleukin-8, erythrocyte sedimentation rate.

A brain-derived neurotrophic factor polymorphism Val66Met identifies fibromyalgia syndrome subgroup with higher body mass index and C-reactive protein.

Revised chronic widespread pain criteria: development from and integration with fibromyalgia criteria.

Fibromyalgia syndrome: approach to management.

Fibromyalgia syndrome: presentation, diagnosis, differential diagnosis, and vulnerability.

Normal cerebrospinal fluid levels of hypocretin-1 (orexin A) in patients with fibromyalgia syndrome.

An internet survey of 2,596 people with fibromyalgia.

CSF versus serum leptin in narcolepsy: is there an effect of hypocretin deficiency?

The promise of substance P inhibitors in fibromyalgia.

Fibromyalgia syndrome: case-based learning.

Fibromyalgia syndrome: new developments in pathophysiology and management. Introduction.

Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine.

Future perspectives in generalised musculoskeletal pain syndromes.

Genetic polymorphisms of the beta2-adrenergic receptor relate to guanosine protein-coupled stimulator receptor dysfunction in fibromyalgia syndrome.

Estimation of minimum clinically important difference for pain in fibromyalgia.

Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia.

Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia.